A 2019 Cochrane review led by Krogsboll examined 17 randomized trials with more than 250,000 adults and found that inviting people to general health checks did not reduce all-cause mortality or cardiovascular mortality. The limitations matter for interpreting that result: many trials began decades ago, before modern risk-stratified prevention and current treatments, participants were often already receiving medical care, and the checks studied were largely unstructured.
The reasonable conclusion is not that assessment is useless. It is that an unfocused ritual, disconnected from risk and from follow-through, underperforms. Both a good annual physical and a good deeper assessment escape that trap the same way: by targeting what is checked to the person and by acting on what is found.
At its best, an annual visit anchors the screening that has actual outcome evidence behind it: blood pressure, lipids, diabetes risk, age-appropriate cancer screening, and immunizations, broadly following the risk- and age-based recommendations graded by the U.S. Preventive Services Task Force. It is inexpensive, usually covered by insurance, and connected to your ongoing medical record.
Its limits are structural. The visit is short, often fifteen to thirty minutes, thresholds are tuned to population averages rather than your trajectory, and acute concerns can crowd out prevention entirely. For many healthy adults it is a floor worth keeping, not a ceiling.
A concentrated assessment can compress advanced imaging, extensive laboratory work, fitness testing, and hours of physician time into a day or two. When that depth is selected thoughtfully, it can surface risks a brief visit would miss and produce a baseline worth building on.
The risks are equally real. Writing in the New England Journal of Medicine in 2008, Dr. Brian Rank argued that executive physicals concentrate untargeted testing on the healthiest people, generate incidental findings that trigger follow-up cascades, and divert clinical resources from higher-need care. Incidental findings are common in broad imaging of asymptomatic adults, and while most prove benign, resolving them costs time, money, and worry. A single concentrated day also cannot show a trend, and without structured follow-through the thick report often ends up as a souvenir.
The weaknesses of the one-day model are not fixed by more testing. They are fixed by time and responsibility: findings interpreted in the context of your history, sequenced into priorities, revisited as new data arrives, and incidental results managed by the same physician team that ordered the scan.
That is the reasoning behind longitudinal models like The Maximum Life's, where Continuum, Core, and Elite pair a baseline with at least a year of interpretation, coordination, and support. The baseline stops being the product and becomes the starting point.
- Do I have risk factors, family history, or symptoms that standard screening under-serves?
- Will each additional test answer a defined question?
- Who will handle incidental or uncertain findings, and how?
- Is there a structured plan for follow-up after the assessment?
- Will the results live somewhere my future care can use them?
- Will the results complement, rather than fragment, my existing care?
An annual physical is typically covered by insurance. Executive assessments and longevity memberships are typically paid out of pocket, though many members can apply HSA or FSA funds toward eligible expenses. Whatever you choose, no assessment can guarantee an outcome or rule out every disease, and any provider who promises otherwise has answered your evaluation for you.